§HealingResearch protocol
PNC-27.
PNC-27 is a synthetic 32‑amino‑acid peptide containing an HDM‑2‑binding domain linked to a membrane‑penetrating sequence, studied preclinically for its selective cytotoxicity toward cancer cells ex...
Research Use Only. PeptiJournal supports private research documentation and calculation support. It does not provide medical advice, human-use directions, or claims of safety or effectiveness.
Cited diluent3 mL
Cited protocol example—review and confirm.
Reference syringe capacity
Concentration
10,000
mcg/mL
Per event
100 mcg
7 events/week
Vials projected
2
16 cited weeks
Calculated volume reference
1.0 units
1mL syringe
PNC-27
1.0u(0.010 mL)
Daily
Cited protocol & reconstitution guide
Source-backed reference fields by phase, including any volume fields authored in the cited guide.
Weeks 1–2
100 mcg (0.10 mg)
Units / volume1 unit (0.01 mL)
Weeks 3–4
200 mcg (0.20 mg)
Units / volume2 units (0.02 mL)
Weeks 5–8
300 mcg (0.30 mg)
Units / volume3 units (0.03 mL)
Weeks 9–12
400 mcg (0.40 mg)
Units / volume4 units (0.04 mL)
Weeks 13–16
500 mcg (0.50 mg)
Units / volume5 units (0.05 mL)
| Phase | Daily reference amount | Units / volume |
|---|---|---|
| Weeks 1–2 | 100 mcg (0.10 mg) | 1 unit (0.01 mL) |
| Weeks 3–4 | 200 mcg (0.20 mg) | 2 units (0.02 mL) |
| Weeks 5–8 | 300 mcg (0.30 mg) | 3 units (0.03 mL) |
| Weeks 9–12 | 400 mcg (0.40 mg) | 4 units (0.04 mL) |
| Weeks 13–16 | 500 mcg (0.50 mg) | 5 units (0.05 mL) |
Cited guide source: View source